Clinical Trials Logo

Clinical Trial Summary

There was no sensitive and specific biomarker for tuberculosis infection, disease progression and predicting the prognosis of treatment. Therefore, the investigators aimed to investigate and evaluate the newer biomarker for the diagnosis of TB infection. To investigate the new biomarker for TB infection, the investigators will recruit the participants including active TB patients, healthy household contacts, healthy community control.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01269268
Study type Observational
Source Yonsei University
Contact
Status Completed
Phase
Start date June 2010
Completion date May 14, 2014

See also
  Status Clinical Trial Phase
Withdrawn NCT05048381 - miRNA in Sweat, a Novel Digital Biomarker for Detection of Active Tuberculosis (TB)
Completed NCT03271567 - Nanodisk-MS Assay for the Diagnosis of Active Pulmonary and Extrapulmonary Tuberculosis in Hospitalized Patients
Not yet recruiting NCT02512484 - Improving the Detection of Active Tuberculosis in Accident and Emergency Departments N/A
Completed NCT02042261 - The Role of Therapeutic Drug Monitoring in Tuberculosis - a Pilot Study N/A
Active, not recruiting NCT05045391 - Pulmonary Aspergillosis in Tuberculosis Patients
Completed NCT04048018 - Performance Evaluation of the VIDAS TB-IGRA Assay.
Recruiting NCT02639936 - New Generation IGRA in Immunocompromised Individuals N/A
Terminated NCT02898623 - Serological Test for the Diagnosis of TB